Scientific Advisory Board

John S. Thompson, MD
Professor of Medicine
University of Kentucky Medical Center

John Thompson, co-developer of the TOL-101 monoclonal antibody, received his medical degree from the University of Chicago, Pritzker School of Medicine. He has been Chief of General Internal Medicine at the University of Chicago and from 1970-1980, was the Vice Chairman of the Department of Medicine, and Director of the Histocompatibility Laboratories at the University of Iowa. Most recently, at the University of Kentucky, he has served as Professor and Chairman of the Department of Medicine, and currently, as the Lexington VAMC Associate Chief of Staff for Research and Development.

Dr. Thompson is certified by the American Board of Internal Medicine. He has served as President of several organizations including the American Society of Histocompatibility and Immunogenetics, the American Board of Histocompatibility and Immunogenetics, and the South Eastern Procurement Foundation, as well as Chair of the UNOS Histocompatibility Committee, Treasurer of the Executive Committee of the National Marrow Donor Foundation, ACGME Residency Review Committee, and has served on numerous committees of the American Board of Internal Medicine.

Throughout his career Dr. Thompson has engaged in research centered on the immunology of solid organ and bone marrow transplantation. He developed the University of Kentucky Clinical Research Organization, as Assistant Vice President for Clinical Research and has authored of over 180 articles in journals such as Nature, the American Journal of Immunology, Transplantation, Blood, Bone Marrow Transplantation, the Journal of Experimental Medicine, the Journal of Clinical Investigation, the New England Journal of Medicine and the Annuals of Internal Medicine.